K173425 is an FDA 510(k) clearance for the SRT-100+. Classified as System, Therapeutic, X-ray (product code JAD), Class II - Special Controls.
Submitted by Sensus Healthcare, Inc. (Boca Raton, US). The FDA issued a Cleared decision on March 23, 2018 after a review of 141 days - within the typical 510(k) review window.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5900 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.